Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Chemistry & Biology|November 5, 2013
Next-generation NAMPT inhibitors identified by sequential high-throughput phenotypic chemical and functional genomic screensChristina J Matheny, Michael C Wei, Michael C Bassik, et al.
Blood|June 14, 2024
Early-life infection depletes preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemiaAli Farrokhi, Tanmaya Atre, Samuel Salitra, et al.
Blood|June 30, 2026
TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosisNaveen Pemmaraju, Adam J Mead, Tim C P Somervaille, et al.
Nature|October 4, 2019
Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesisAkihide Yoshimi, Kuan-Ting Lin, Daniel H Wiseman, et al.
Cancer Discovery|May 8, 2016
ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL LeukemiaLi Zhu, Qin Li, Stephen H K Wong, et al.
British Journal of Haematology|May 3, 2026
Real-world treatment patterns and outcomes in accelerated and blast-phase myeloproliferative neoplasms: Insights from a large multi-centre cohort analysis in the United KingdomAlexandros Rampotas, Gabriel Naylor-Layland, Clare Brown, et al.
Cancer Research|September 29, 2018
CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic LeukemiaJesús Duque-Afonso, Chiou-Hong Lin, Kyuho Han, et al.
The American Journal of Surgical Pathology|January 29, 2008
A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumorsInigo Espinosa, Cheng-Han Lee, Mi Kyung Kim, et al.
Genome Research|April 1, 2011
MicroRNA programs in normal and aberrant stem and progenitor cellsChristopher P Arnold, Ruoying Tan, Baiyu Zhou, et al.
Cancer Cell|July 12, 2011
Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complexMichael Heuser, Haiyang Yun, Tobias Berg, et al.
Pageof 16